New sedation approach tested to help older ICU patients survive and recover
NCT ID NCT06251375
Summary
This study is testing whether using a specific sedative medication called dexmedetomidine early in treatment helps older patients on breathing machines survive and recover better. Researchers will compare it to a placebo in 300 patients aged 65 and older who are critically ill in intensive care. The main goal is to see if this sedation approach reduces deaths within 90 days and helps patients spend fewer days on ventilators and with complications like delirium.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.